X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (891) 891
Publication (54) 54
Book Review (18) 18
Book / eBook (7) 7
Book Chapter (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (844) 844
index medicus (622) 622
rheumatology (591) 591
spondylarthritis - drug therapy (496) 496
male (455) 455
female (436) 436
adult (381) 381
ankylosing-spondylitis (375) 375
middle aged (320) 320
antirheumatic agents - therapeutic use (268) 268
spondyloarthritis (248) 248
spondylarthritis - diagnosis (229) 229
tumor necrosis factor-alpha - antagonists & inhibitors (226) 226
ankylosing spondylitis (218) 218
arthritis (209) 209
treatment outcome (205) 205
rheumatoid-arthritis (175) 175
spondylarthritis (159) 159
double-blind (150) 150
axial spondyloarthritis (144) 144
severity of illness index (139) 139
infliximab (137) 137
psoriatic-arthritis (122) 122
spondylitis, ankylosing - drug therapy (119) 119
aged (117) 117
etanercept (116) 116
spondylarthritis - immunology (116) 116
magnetic resonance imaging (112) 112
inflammation (110) 110
abridged index medicus (109) 109
spondylarthritis - complications (109) 109
anti-inflammatory agents, non-steroidal - therapeutic use (108) 108
antibodies, monoclonal - therapeutic use (108) 108
young adult (106) 106
society classification criteria (104) 104
spondylarthritis - diagnostic imaging (104) 104
rheumatoid arthritis (101) 101
adalimumab (93) 93
care and treatment (93) 93
spondylarthritis - pathology (92) 92
disease (91) 91
efficacy (90) 90
medicine & public health (90) 90
internal medicine (88) 88
spondyloarthropathies (87) 87
rheumatic diseases (86) 86
placebo-controlled trial (84) 84
disease-activity (83) 83
inflammatory diseases (82) 82
prevalence (82) 82
arthritis, rheumatoid - drug therapy (81) 81
spondylarthritis - epidemiology (81) 81
spondylarthritis - physiopathology (80) 80
radiography (77) 77
diagnosis (76) 76
classification (74) 74
risk factors (73) 73
disease progression (72) 72
patients (72) 72
radiographic progression (72) 72
criteria (69) 69
therapy (67) 67
retrospective studies (65) 65
research (64) 64
adolescent (63) 63
psoriasis (63) 63
psoriatic arthritis (63) 63
spondylarthritis - therapy (62) 62
active ankylosing-spondylitis (60) 60
follow-up studies (60) 60
prospective studies (59) 59
quality of life (59) 59
sacroiliitis (56) 56
receptors, tumor necrosis factor - therapeutic use (55) 55
animals (54) 54
antirheumatic agents - adverse effects (54) 54
immunoglobulin g - therapeutic use (54) 54
immunology (54) 54
time factors (54) 54
biological products - therapeutic use (53) 53
recommendations (53) 53
safety (53) 53
spondylitis (52) 52
cross-sectional studies (51) 51
research article (51) 51
cohort studies (50) 50
antibodies, monoclonal, humanized - therapeutic use (49) 49
spondylitis, ankylosing - diagnosis (49) 49
tumor necrosis factor-tnf (48) 48
arthritis, psoriatic - drug therapy (47) 47
drug therapy (47) 47
spondylarthritis - blood (47) 47
nonsteroidal antiinflammatory drugs (45) 45
diagnosis, differential (44) 44
medicine, general & internal (44) 44
sacroiliac joint - pathology (43) 43
classification criteria (42) 42
musculoskeletal diseases (42) 42
studies (42) 42
magnetic resonance imaging - methods (41) 41
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (817) 817
German (32) 32
French (25) 25
Spanish (9) 9
Russian (5) 5
Croatian (4) 4
Portuguese (3) 3
Italian (2) 2
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
Japanese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 970 - 978
Objective To assess the effect of comedication with conventional synthetic disease modifying antirheumatic drugs (csDMARDs) on retention to tumour necrosis... 
RHEUMATOID-ARTHRITIS | EFFICACY | Anti-TNF | METHOTREXATE | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | Spondyloarthritis | SOCIETY CLASSIFICATION CRITERIA | Ankylosing Spondylitis | DMARDs (synthetic) | IMMUNOGENICITY | TREATMENT RESPONSE | NECROSIS FACTOR THERAPY | INFLIXIMAB | CONTINUATION | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Humans | Middle Aged | Spondylitis, Ankylosing - drug therapy | Proportional Hazards Models | Immunoglobulin G - therapeutic use | Antibodies, Monoclonal - therapeutic use | Male | Spondylarthritis - drug therapy | Treatment Outcome | Methotrexate - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Survival Analysis | Adult | Female | Adalimumab | Drug Therapy, Combination | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Care and treatment | Antirheumatic agents | Tumor necrosis factor inhibitors | Spondyloarthropathies | Dosage and administration | Research | Ankylosing spondylitis | Risk factors | Studies | Inflammatory bowel disease | Immunoglobulins | Psoriasis | Disease | Socioeconomic factors | TNF inhibitors | Tumor necrosis factor-TNF | Arthritis | Patients | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | Klinisk medicin
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2014, Volume 73, Issue 1, pp. 101 - 107
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2014, Volume 73, Issue 1, pp. 6 - 16
Journal Article
Journal Article